Kyverna Therapeutics, Inc. - Common Stock, par value $0.00001 per share (KYTX)
CUSIP: 501976104
Q4 2024 13F Holders as of 31 Dec 2024
- Type / Class
- Equity / Common Stock, par value $0.00001 per share
- Shares outstanding
- 56,833,213
- Total 13F shares
- 28,863,400
- Share change
- -1,129,777
- Total reported value
- $107,952,189
- Put/Call ratio
- 6%
- Price per share
- $3.74
- Number of holders
- 87
- Value change
- -$6,920,913
- Number of buys
- 46
- Number of sells
- 42
Quarterly Holders Quick Answers
What is CUSIP 501976104?
CUSIP 501976104 identifies KYTX - Kyverna Therapeutics, Inc. - Common Stock, par value $0.00001 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 501976104:
Top shareholders of KYTX - Kyverna Therapeutics, Inc. - Common Stock, par value $0.00001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Vida Ventures Advisors, LLC |
13F
|
Company |
8%
|
4,523,924
|
$22,121,988 | — | 30 Sep 2024 | |
| Bain Capital Life Sciences Investors, LLC |
13F
3/4/5
|
Company · 10%+ Owner |
5.9%
|
3,368,370
|
$16,471,329 | — | 30 Sep 2024 | |
| Northpond Ventures, LLC |
13F
|
Company |
5.7%
|
3,255,426
|
$15,919,033 | — | 30 Sep 2024 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
4.2%
|
2,387,352
|
$11,674,152 | — | 30 Sep 2024 | |
| Novo Holdings A/S |
13F
|
Company |
3.3%
|
1,850,000
|
$9,046,500 | — | 30 Sep 2024 | |
| BlackRock, Inc. |
13F
|
Company |
2.7%
|
1,520,261
|
$7,434,076 | — | 30 Sep 2024 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
2.2%
|
1,253,556
|
$6,129,889 | — | 30 Sep 2024 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
1.6%
|
936,961
|
$5,256,351 | — | 30 Sep 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
1.8%
|
1,006,707
|
$4,922,797 | — | 30 Sep 2024 | |
| DEERFIELD MANAGEMENT COMPANY, L.P. |
13F
|
Company |
1.6%
|
918,892
|
$4,493,382 | — | 30 Sep 2024 | |
| Insight Holdings Group, LLC |
13F
|
Company |
1.6%
|
912,915
|
$4,464,154 | — | 30 Sep 2024 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
1.1%
|
628,222
|
$3,073,000 | — | 30 Sep 2024 | |
| MBB PUBLIC MARKETS I LLC |
13F
|
Company |
1.1%
|
614,477
|
$3,004,793 | — | 30 Sep 2024 | |
| EcoR1 Capital, LLC |
13F
|
Company |
0.79%
|
450,000
|
$2,200,500 | — | 30 Sep 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.78%
|
443,312
|
$2,168,069 | — | 30 Sep 2024 | |
| STATE STREET CORP |
13F
|
Company |
0.57%
|
326,192
|
$1,595,079 | — | 30 Sep 2024 | |
| SPHERA FUNDS MANAGEMENT LTD. |
13F
|
Company |
0.44%
|
248,651
|
$1,215,903 | — | 30 Sep 2024 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
0.41%
|
235,123
|
$1,149,752 | — | 30 Sep 2024 | |
| Integral Health Asset Management, LLC |
13F
|
Company |
0.35%
|
200,000
|
$978,000 | — | 30 Sep 2024 | |
| E Fund Management Co., Ltd. |
13F
|
Company |
0.33%
|
189,432
|
$926,322 | — | 30 Sep 2024 | |
| Rock Springs Capital Management LP |
13F
|
Company |
0.31%
|
178,963
|
$875,129 | — | 30 Sep 2024 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.29%
|
166,635
|
$814,845 | — | 30 Sep 2024 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.27%
|
153,787
|
$752,018 | — | 30 Sep 2024 | |
| PERCEPTIVE ADVISORS LLC |
13F
|
Company |
0.26%
|
150,000
|
$733,500 | — | 30 Sep 2024 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.24%
|
137,739
|
$673,544 | — | 30 Sep 2024 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.24%
|
133,937
|
$654,952 | — | 30 Sep 2024 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.22%
|
122,854
|
$600,756 | — | 30 Sep 2024 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
0.22%
|
122,777
|
$600,380 | — | 30 Sep 2024 | |
| Affinity Asset Advisors, LLC |
13F
|
Company |
0.21%
|
119,900
|
$586,311 | — | 30 Sep 2024 | |
| MORGAN STANLEY |
13F
|
Company |
0.21%
|
119,794
|
$585,793 | — | 30 Sep 2024 | |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC |
13F
|
Company |
0.18%
|
101,900
|
$498,291 | — | 30 Sep 2024 | |
| TD ASSET MANAGEMENT INC |
13F
|
Company |
0.16%
|
90,242
|
$471,966 | — | 30 Sep 2024 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.14%
|
79,803
|
$390,237 | — | 30 Sep 2024 | |
| BARCLAYS PLC |
13F
|
Company |
0.12%
|
70,167
|
$343,117 | — | 30 Sep 2024 | |
| Cubist Systematic Strategies, LLC |
13F
|
Company |
0.12%
|
68,958
|
$337,205 | — | 30 Sep 2024 | |
| XTX Topco Ltd |
13F
|
Company |
0.09%
|
52,792
|
$258,153 | — | 30 Sep 2024 | |
| Hudson Bay Capital Management LP |
13F
|
Company |
0.09%
|
52,035
|
$254,451 | — | 30 Sep 2024 | |
| Alyeska Investment Group, L.P. |
13F
|
Company |
0.08%
|
45,000
|
$220,050 | — | 30 Sep 2024 | |
| Verition Fund Management LLC |
13F
|
Company |
0.08%
|
44,626
|
$218,221 | — | 30 Sep 2024 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.08%
|
43,266
|
$211,569 | — | 30 Sep 2024 | |
| Woodline Partners LP |
13F
|
Company |
0.07%
|
42,477
|
$207,713 | — | 30 Sep 2024 | |
| ExodusPoint Capital Management, LP |
13F
|
Company |
0.07%
|
41,984
|
$205,000 | — | 30 Sep 2024 | |
| NORGES BANK |
13F
|
Company |
0.07%
|
40,000
|
$195,600 | — | 30 Sep 2024 | |
| PRUDENTIAL FINANCIAL INC |
13F
|
Company |
0.07%
|
39,570
|
$193,497 | — | 30 Sep 2024 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.07%
|
39,193
|
$191,654 | — | 30 Sep 2024 | |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE |
13F
|
Company |
0.07%
|
37,794
|
$184,813 | — | 30 Sep 2024 | |
| Deutsche Girozentrale DekaBank |
13F
|
Individual |
0.01%
|
7,500
|
$181,000 | — | 30 Sep 2024 | |
| Point72 Asset Management, L.P. |
13F
|
Company |
0.06%
|
34,482
|
$168,615 | — | 30 Sep 2024 | |
| BALYASNY ASSET MANAGEMENT L.P. |
13F
|
Company |
0.06%
|
33,308
|
$162,876 | — | 30 Sep 2024 | |
| ALPS ADVISORS INC |
13F
|
Company |
0.06%
|
33,056
|
$161,644 | — | 30 Sep 2024 |
Institutional Holders of Kyverna Therapeutics, Inc. - Common Stock, par value $0.00001 per share (KYTX) as of Q4 2024
As of 31 Dec 2024,
Kyverna Therapeutics, Inc. - Common Stock, par value $0.00001 per share (KYTX) was held by
87 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
28,863,400 shares.
The largest 10 holders included
Vida Ventures Advisors, LLC, GILEAD SCIENCES, INC., Bain Capital Life Sciences Investors, LLC, JPMORGAN CHASE & CO, Novo Holdings A/S, BlackRock, Inc., VANGUARD GROUP INC, Insight Holdings Group, LLC, MILLENNIUM MANAGEMENT LLC, and FRANKLIN RESOURCES INC.
This page lists
87
institutional shareholders reporting positions in this security
for the Q4 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2024 vs Q3 2024 Across Filers
Q3 2024 holders
92
Q4 2024 holders
87
Holder diff
-5
| Investor | Q3 2024 Shares | Q4 2024 Shares | Share Diff | Share Chg % | Q3 2024 Value $ | Q4 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.